Despite significant progress, cancer research faces several challenges. These include the heterogeneity of tumors, which makes it difficult to develop one-size-fits-all treatments, and the ability of cancer cells to develop resistance to therapies. Additionally, the high cost of clinical trials and the need for more effective patient stratification pose ongoing obstacles.
